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ABSTRACT: Sulfoximines are of considerable interest for
incorporation into medicinal compounds. A convenient
synthesis of N-protected sulfoximines is achieved, under mild
conditions, by rhodium-catalyzed transfer of carbamates to
sulfoxides. The ﬁrst examples of 4-membered thietane-
oximines are prepared. Sulfoximines bearing Boc and Cbz
groups are stable to further cross coupling reactions, and readily deprotected. This method may facilitate the preparation of NH-
sulfoximines providing improved (global) deprotection strategies, which is illustrated in the synthesis of methionine sulfoxide
(MSO).
■ INTRODUCTION
Sulfoximine derivatives have received the attention of synthetic
chemists over several decades.1 Many applications have
concerned their use as ligands, and auxiliaries,2,3 and recently
they have been employed as directing groups for catalytic ortho-
CH functionalization.4 Since the identiﬁcation of methionine
sulfoximine (MSO),5 the ﬁrst sulfoximine discovered, there has
also been signiﬁcant interest in their eﬀects on biological
systems (Figure 1).6
MSO and buthionine sulfoximine (BSO) are useful tools for
the inhibition of the biosynthesis of glutathione (GSH).7
However, the more general use of the sulfoximine group in
medicinal chemistry follows the development of BAY 1000394,
a pan-CDK inhibitor that is currently in phase 1 clinical trials
for cancer in patients with advanced solid tumors.8 In this case,
the sulfoximine conferred improved solubility versus a
sulfonamide predecessor. Sulfoximines are now increasingly
intriguing options for inclusion in drug discovery programs.9
Much of this interest is due to their attractive structural features
to improve physicochemical properties. These polar and stable
functional groups oﬀer hydrogen bond acceptors and donors,
aid solubility, introduce asymmetry at the sulfur atom and
provide additional points of substitution through the nitrogen
atom.
Advances in their medicinal chemistry usage have necessarily
followed the development of improved synthetic routes.10 Early
approaches to sulfoximine synthesis required forcing and
hazardous conditions such as sodium azide in concentrated
acid.11 Recently, safer and more tolerant nitrogen transfer
methods have been reported, both through imidation of
sulfoxides,12,14−18 and the reverse, imidation of sulﬁdes to form
sulﬁlimines followed by oxidation.13 In particular, there has
been considerable eﬀort aimed at the development of methods
for transition metal-catalyzed N-transfer to sulfoxides via metal
nitrenoid species (Scheme 1).
The transfer of sulfonamide groups using activated nitrogen
species (e.g., PhI = NNs) has been achieved with Cu,14 Rh,15
Ag,16 and Fe17 catalysis (Scheme 1a). While Ts groups are
challenging to deprotect, the Ns group can be removed by
treatment with thiophenol and cesium carbonate.16 Bolm
demonstrated that triﬂuoroacetamide could be introduced,
using Rh2(OAc)4 and PhI(OAc)2 to generate the active N-
species in situ (Scheme 1b).15 Treatment with K2CO3/MeOH
eﬀected deprotection. The transfer of nitrenes derived from
simple amides has been unsuccessful under hypervalent iodine
mediated conditions. Therefore, Bolm developed the use of
1,4,2-dioxazol-5-ones to transfer a range of amides requiring
photochemical activation and a Ru catalyst (Scheme 1c).18
Richards reported a Rh-catalyzed method for the direct
preparation of NH-sulfoximines using O-(2,4-dinitrophenyl)-
hydroxyl-amine with Rh2(esp)2 as the catalyst.
19 Methods for
N-functionalization of NH-sulfoximines have also undergone
signiﬁcant recent development, including methods for N-
arylation,20 acylation,21 alkynylation,22 and alkylation.23
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Figure 1. Sulfoximines in biologically active compounds.
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We required protected sulfoximines that would be stable to
nucleophiles and bases used in further synthetic trans-
formations prior to revealing the NH-sulfoximine. We identiﬁed
sulfoximine carbamates as most suitable. Bolm has previously
demonstrated that N-Boc sulfoximines were stable to Pd-
catalyzed cross-coupling at other positions in the molecule.24 In
that study, the Boc group was introduced by the reaction of
preformed NH-sulfoximines with (Boc)2O. Similarly, in the
reported synthesis of BAY1000394, an NH-sulfoximine
intermediate was protected as an ethyl carbamate during
reduction of a nitro group, before later deprotection.8 To date,
there is no direct and general method for the preparation of
carbamate-protected sulfoximines from sulfoxides.25 The only
previous investigation into the preparation of Boc sulfoximines
from sulfoxides by Bach used Boc-azide (Scheme 1d).26
However, the potentially explosive nature of BocN3 has limited
the application of this method.
We considered that direct methods for the syntheses of
carbamate sulfoximines would be valuable to provide protected
sulfoximines that may be revealed selectively or when
synthetically most advantageous. In addition, they may provide
interesting groups in their own right in medicinal chemistry, or
as ligands or auxiliaries. Here we report the direct preparation
of sulfoximine carbamates including Boc and Cbz as well as
methyl, ethyl, phenyl and allyl derivatives, by the Rh-catalyzed
nitrogen transfer of carbamates (Scheme 1e). We demonstrate
the stability of the Boc and Cbz groups to further
manipulations of sulfoximines, in the form of cross-coupling
reactions, as well as their removal. We also report the ﬁrst
preparation of thietane-oximines, and a preparation of MSO via
the Boc-sulfoximine.
■ RESULTS AND DISCUSSION
There are few examples of intermolecular transfer of nitrenoids
derived from simple carbamates in any transformation.27
Inspired by the Bolm method,15 our study began investigating
conditions employing BocNH2 and PhI(OAc)2, intending to
generate an activated BocN=IPh species in situ to transfer to a
sulfoxide. Using rhodium catalysis and magnesium oxide as
base, we were delighted to observe the direct formation of the
N-Boc sulfoximine 2a from sulfoxide 1a in good yield (Table 1,
entry 1).25
From this starting point, we intended to reduce the reaction
times and minimize the excess of reagents required, due to the
excess carbamate causing diﬃculties in puriﬁcation. Initially
reducing the equivalents of carbamate and PhI(OAc)2 led to a
reduction of yield (entries 2−3). Warming the reaction gave a
slight improvement (entry 4). The crucial variables were the
interplay of time and temperature. With the larger excess of
reagents, the reaction time could be signiﬁcantly reduced, and
warming to 40 °C gave an 87% yield (entries 5 and 6). At 40
°C with an 8 h reaction time, complete conversion was
observed (entry 7). Under these optimized conditions, a 98%
yield of the desired N-Boc sulfoximine 2a was obtained (0.6
mmol scale, Scheme 2). No reaction occurred in the absence of
the Rh-catalyst (entry 8). At a 4 mmol scale 94% conversion
and 80% isolated yield was obtained with 8 h reaction time.
The N-transfer was stereospeciﬁc as performing the reaction on
(S)-tolyl methyl sulfoxide (er 97:3) led to complete retention of
the er in N-Boc-sulfoximine 2a.28,29 Importantly, the reaction
conditions are not sensitive to air and water; all reactions were
performed under air without using anhydrous dichloromethane.
Next, the scope of the reaction was examined using BocNH2
as the nitrogen source (Scheme 2). Variation of the electronics
of the aromatic component by using 4-chlorophenylsulfoxide
2b also gave a good yield. With the isopropyl substituted
sulfoximine 2c the yield was somewhat reduced, as might be
expected from the increased steric hindrance. Other substituted
alkyl derivatives (2d and 2e) gave excellent yields, as did
Scheme 1. Catalytic Approaches to Protected Sulfoximines
Table 1. Selected Optimization to N-Boc-Sulfoximine 2a
entrya time (h) temp (°C) BocNH2 (equiv) PhI(OAc)2 (equiv) convn
b yield (%)c
1 18 20 2.0 1.5 86 85
2 18 20 1.3 1.3 73 72
3 18 20 1 1 61 59
4 18 40 1 1 68 63
5 6 20 2 1.5 56 54
6 6 40 2 1.5 88 87
7 8 40 1.5 1.5 100 98
8d 8 40 1.5 1.5 0 0
aReactions performed on 0.3 mmol scale at 0.1 M 1a. bConversion measured by 1H NMR of crude reaction mixture through comparison with an
internal standard (1,3,5-trimethoxybenzene). cYield of isolated product. dReaction performed in absence of Rh2(OAc)4.
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diphenyl sulfoxide and phenyl vinyl sulfoxide to aﬀord
respectively sulfoximines 2f and 2g. Dibenzyl sulfoxide and
tetrahydrothiophene 1-oxide were also successful providing 2h
and 2i.30 Methyl carbamate and ethyl carbamate were equally
reactive, under the same conditions, generating the correspond-
ing sulfoximines 3 and 4 in high yield (Scheme 2).
Attempts to directly translate the optimal reaction conditions
used above to form Cbz protected sulfoximines gave a
signiﬁcant reduction of the yield (37%). A similar reduction
in yield was observed with phenyl carbamate; presumably due
to an unfavorable coordination of the π-system to the catalyst
slowing the reaction. The reaction parameters were examined
again, and ultimately, increasing the concentration of the
reaction from 0.1 to 0.3 M in sulfoxide gave improved yields
(60% yield for 5a, Scheme 3). Under these conditions, for both
benzyl and phenyl carbamates, good yields of the correspond-
ing sulfoximines 5b,g, and 6a,h, were achieved, though notably
lower than the alkyl carbamates. The use of allyl carbamate was
also successful under the more concentrated reaction
conditions, forming sulfoximines 7a and 7b, but side reactions
reduced the yield (Scheme 3). Dimethylurea, methyl 4-
aminobenzoate and 2-aminopyridine were also examined as
possible reagents but each returned only starting materials.31
Next, as part of our interests in the synthesis of novel 4-
membered ring heterocycles,32,33 we examined the preparation
of unusual 4-membered cyclic sulfoximines.34 Thietane oxide 8
was prepared by oxidation of thietane with hydrogen peroxide,
as previously reported.33d This substrate proved to be reactive
and was successful for all carbamates under the conditions
reported above (Scheme 4). The alkyl carbamates gave the
thietane-oximines 9-11 in excellent yields, where as the benzyl,
phenyl and allyl gave lower yields (12-14), indicating the
relative reactivity of the nitrogen sources. Further studies with
these compounds will be reported in due course.
The stability and utility of the orthogonally protected N-Cbz-
and N-Boc-chlorophenyl sulfoximines (2b and 5b) was
demonstrated in Suzuki cross-couplings with aryl boronic
acids,35,36 and Fe-catalyzed cross-couplings of alkyl Grignard
reagents (Scheme 5).29,37 The couplings proceeded in good
yields in each case, leading to further elaborated sulfoximine
derivatives (15−18).
The Boc- and Cbz-sulfoximines 2a and 5a were also readily
deprotected using standard conditions to generate the free NH-
sulfoximines in good to excellent yields, highlighting the
convenience of these N-carbamate sulfoximines (Scheme 6).
The parent thietaneoximine 20 was prepared by deprotection
of N-Boc derivative 9 using TFA.
To illustrate the potential for synthetic advantage of
introducing a Boc group, we prepared MSO with a ﬁnal global
Scheme 2. Reaction Scope with Alkyl Carbamates Scheme 3. Reaction Scope Performed at Higher
Concentration; Benzyl, Phenyl, and Allyl Carbamates
Scheme 4. Thietane-oximines
Scheme 5. Cross Coupling of Chloro-Sulfoximine 2b and 5b
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deprotection step, a target recently examined by Bolm to assess
alternative protecting group strategies.38 Our approach involved
the direct formation of the N-Boc sulfoximine 22, as a 1:1
mixture of diastereoisomers, from protected methionine
sulfoxide 21. Fully protected 22 could be readily puriﬁed.
The sulfoximine Boc group was then removed, along with the
other Boc group and tert-butyl ester, under acidic conditions to
aﬀord MSO in 54% yield over the two steps following
puriﬁcation by ion exchange chromatography (Scheme 7).
■ CONCLUSIONS
We have developed a general and convenient procedure for the
preparation of sulfoximine carbamates. Under rhodium
catalysis, BocNH2 and CbzNH2, as well as methyl, ethyl,
phenyl, and allyl carbamates are transferred stereospeciﬁcally to
a range sulfoxides in high yields. We expect these sulfoximine
carbamates to provide interesting variations to chiral auxiliaries
or ligands, as well as new motifs for medicinal chemistry. This
approach may facilitate synthetic planning by allowing ﬂexible
removal of protecting groups to access NH sulfoximines.
■ EXPERIMENTAL SECTION
General Considerations. All reactions were carried out under
atmospheric conditions using solvents without speciﬁc drying unless
otherwise stated. Anhydrous THF was obtained by ﬁltration through
alumina drying columns. Commercial reagents were used as supplied,
or puriﬁed by standard techniques where necessary. Flash column
chromatography was performed using 230−400 mesh silica, with the
indicated solvent system according to standard techniques. Analytical
thin-layer chromatography (TLC) was performed on precoated glass-
backed or aluminum-backed silica gel plates. Visualization of the
developed chromatogram was performed by UV absorbance (254 nm)
and/or stained with aqueous potassium permanganate solution or an
acidic vanillin solution. Infrared spectra (νmax, FT-IR ATR) were
recorded in reciprocal centimeters (cm−1). Nuclear magnetic
resonance spectra were recorded on 400 MHz spectrometers.
Chemical shifts for 1 H NMR spectra are recorded in parts per
million (ppm) from tetramethylsilane with the solvent resonance as
the internal standard (chloroform: δ = 7.26 ppm, D2O: δ = 4.79 ppm,
DMSO δ = 2.50 ppm). Data are reported as follows: chemical shift
(multiplicity [s = singlet, d = doublet, t = triplet, q = quartet, sept =
septet, m = multiplet, br = broad, app = apparent], coupling constant
(in Hz), integration and assignment). 13C NMR spectra were recorded
with complete proton decoupling. Chemical shifts are reported in ppm
from tetramethylsilane with the solvent resonance as the internal
standard (13CDCl3: 77.16 ppm, (
13CD3)2SO: δ = 39.5 ppm). Melting
points are uncorrected. Observed rotations were recorded at the
indicated temperature (T °C) and were converted to the
corresponding speciﬁc rotations. Preparation of Sulfoxides 1a-e, 8.
Sulfoxides were obtained from commercial sources (1f−i), or by
oxidation from the corresponding sulﬁdes (1a−e, 8) with mCPBA or
H2O2.
39−44,33d (S)-1-Methanesulﬁnyl-4-methyl-benzene ((S)-1a) was
prepared according to the Jackson method45 (er 97:3).
Preparation of N-Boc, N-CO2Me, and N-CO2Ethyl Sulfox-
imines (2,3,4,9,10,11). General Procedure 1 To a suspension of the
sulfoxide (0.6 mmol), carbamate (0.9 mmol), MgO (97 mg, 2.4
mmol), and Rh2(OAc)4 (7.0 mg, 2.5 mol %) in CH2Cl2 (6 mL) was
added PhI(OAc)2 (290 mg, 0.90 mmol) at rt. The resulting mixture
was stirred for 8 h at 40 °C. The reaction mixture was ﬁltered through
a pad of diatomaceous earth and concentrated in vacuo, and the
resulting residue was puriﬁed by ﬂash chromatography (SiO2) to the
give N-substituted sulfoximine.
tert-Butyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (2a). Prepared according to General Procedure 1 using
sulfoxide 1a (97 mg, 0.63 mmol) and tert-butylcarbamate (111 mg,
0.945 mmol). Puriﬁcation by ﬂash chromatography (50% EtOAc/
hexane) aﬀorded N-Boc sulfoximine 2a (158 mg, 98%) as a white
solid. Rf = 0.5 (50% EtOAc/hexane); mp =108−112 °C; IR (ﬁlm) νmax
(cm−1): 3034, 2980, 2934, 1664, 1267, 1149, 864, 783; 1H NMR (400
MHz, CDCl3): δ 7.84 (app d, J = 8.3 Hz, 2H), 7.37 (app d, J = 8.3 Hz,
2H), 3.21 (s, 3H), 2.44 (s, 3H), 1.38 (s, 9H); 13C{1H} NMR (101
MHz, CDCl3): δ 158.0, 144.9, 135.8 (2C), 130.4 (2C), 127.5, 80.6,
45.0, 28.2 (3C), 21.7; HRMS (ESI-TOF) m/z: calcd for C13H20NO3S
+
[M + H]+ 270.1164; found 270.1175.
(S)-tert-Butyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate ((S)-2a). [α]25D = +39 (c 1.0, acetone); Chiral HPLC: OD
column, 93:7 (Hexane:i-PrOH), 1.0 mL/min, 98:2 er, (S)-isomer
(major): 16.8 min, (R)-isomer (minor): 20.0 min.
tert-Butyl[(4-chlorophenyl)(ethyl)oxido-λ6-sulfanylidene]-
carbamate (2b). Prepared according to General Procedure 1 using
sulfoxide 1b (117 mg, 0.62 mmol) and tert-butylcarbamate (109 mg,
0.930 mmol). Puriﬁcation by ﬂash chromatography (40% EtOAc/
hexane) aﬀorded N-Boc-sulfoximine 2b (160 mg, 85%) as a white
solid. Rf = 0.4 (40% EtOAc/hexane); mp =130−136 °C; IR (ﬁlm) νmax
(cm−1): 3034, 2980, 2934, 1664, 1267, 1149, 864, 783; 1H NMR (400
MHz, CDCl3): δ 7.89−7.80 (m, 2H), 7.59−7.49 (m, 2H), 3.44−3.25
(m, 2H), 1.37 (s, 9H), 1.24 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3): δ 157.7, 140.6, 135.2, 130.0 (2C), 129.7 (2C), 80.8,
50.8, 28.1 (3C), 7.0; HRMS (ESI-TOF) m/z: calcd for
C13H19ClNO3S
+ [M + H]+ 304.0774, found 304.0777.
tert-Butyl[(4-methylphenyl)(oxido)propan-2-yl-λ6-sulfanylidene]-
carbamate (2c). Prepared according to General Procedure 1 using
sulfoxide 1c (118 mg, 0.65 mmol) and tert-butylcarbamate (114 mg,
0.970 mmol). Puriﬁcation by ﬂash chromatography (50% EtOAc/
hexane) aﬀorded N-Boc-sulfoximine 2c (104 mg, 54%) as a white
solid. Rf = 0.5 (50% EtOAc/hexane); mp =76−80 °C; IR (ﬁlm) νmax
(cm−1): 2977, 1667, 1272, 1249, 1155, 1104, 892, 866, 660; 1H NMR
(400 MHz, CDCl3): δ 7.75 (app d, J = 8.2 Hz, 2H), 7.37 (app d, J =
8.2 Hz, 2H), 3.46 (sept., J = 6.8 Hz 1H), 2.45 (s, 3H), 1.40 (d, J = 6.8
Hz, 3H), 1.34 (s, 9H), 1.19 (d, J = 6.8 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3): δ 158.3, 144.6, 132.1, 130.1 (2C), 129.1 (2C), 80.2,
56.3, 28.1 (3C), 21.7, 15.9, 15.2; HRMS (ESI-TOF) m/z: calcd for
C15H24NO3S
+ [M + H]+ 298.1477, found 298.1480.
te r t -Buty l [ ( ch loromethy l ) (4 -methy lpheny l )ox ido-λ 6 -
sulfanylidene]carbamate (2d). Prepared according to General
Procedure 1 using sulfoxide 1d (121 mg, 0.64 mmol) and tert-
butylcarbamate (112 mg, 0.960 mmol). Puriﬁcation by ﬂash
chromatography (20% EtOAc/hexane); aﬀorded N-Boc-sulfoximine
2d (180 mg, 93%) as a white solid. Rf= 0.35 (20% EtOAc/hexane); mp
=87−91 °C; IR (ﬁlm) νmax (cm−1): 2978, 1666, 1274, 1244, 1143, 902,
870, 787, 751; 1H NMR (400 MHz, CDCl3): δ 7.90 (app d, J = 8.3
Hz, 2H), 7.41 (app d, J = 8.3 Hz, 2H), 5.11 (d, J = 11.9 Hz, 1H), 4.81
(d, J = 11.9 Hz, 1H), 2.48 (s, 3H), 1.45 (s, 9H); 13C{1H} NMR (101
MHz, CDCl3): δ 157.4, 146.1, 130.5, 130.3 (2C), 129.5 (2C), 81.4,
58.8, 28.1 (3C), 21.8; HRMS (ESI-TOF) m/z: calcd for
C15H21N2O3SClNa
+ [M+ CH3CN + Na]
+ 367.0859, found 367.0858.
tert-Butyl [ (4-methylphenyl) (oxido)(2-phenylethyl ) -λ6-
sulfanylidene]carbamate (2e). Prepared according to General
Procedure 1 using sulfoxide 1e (146 mg, 0.60 mmol) and tert-
butylcarbamate (105 mg, 0.90 mmol). Puriﬁcation by ﬂash
Scheme 6. Boc and Cbz Deprotection of Sulfoximines
Scheme 7. Synthesis of MSO via 1-Pot Deprotection
The Journal of Organic Chemistry Article
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chromatography (30% EtOAc/hexane) aﬀorded N-Boc-sulfoximine 2e
(168 mg, 78%) as a white solid. Rf = 0.5 (30% EtOAc/hexane); mp
=125−129 °C; IR (ﬁlm) νmax (cm−1): 2979, 1651, 1274, 1143, 893,
855, 762, 726; 1H NMR (400 MHz, CDCl3): δ 7.87 (app d, J = 8.3
Hz, 2H), 7.41 (app d, J = 8.3 Hz, 2H), 7.31−7.19 (m, 3H), 7.15−7.06
(m, 2H), 3.67 (ddd, J = 13.8, 12.2, 5.0 Hz, 1H), 3.51 (ddd, J = 13.8,
12.2, 5.0 Hz, 1H), 3.13 (app. td, J = 13, 5.0 Hz, 1H), 2.97 (app. td, J =
13, 5.0 Hz, 1H), 2.49 (s, 3H), 1.42 (s, 9H); 13C{1H} NMR (101 MHz,
CDCl3): δ 158.0, 144.9, 137.1, 134.2, 130.4 (2C), 128.9 (2C), 128.5
(2C), 128.1 (2C), 127.1, 80.6, 57.5, 28.4, 28.1 (3C), 21.7; HRMS
(ESI-TOF) m/z: calcd for C20H26NO3S
+ [M + H]+ 360.1633, found
360.1639.
tert-Butyl[oxido(diphenyl)-λ6-sulfanylidene]carbamate (2f). Pre-
pared according to General Procedure 1 using sulfoxide 1f (127 mg,
0.63 mmol) and tert-butylcarbamate (110 mg, 0.940 mmol).
Puriﬁcation by ﬂash chromatography (30% EtOAc/hexane) aﬀorded
N-Boc-sulfoximine 2f (139 mg, 70%) as a white solid. Rf = 0.3 (30%
EtOAc/hexane); mp =97−102 °C; IR (ﬁlm) νmax (cm−1): 2985, 1687,
1446, 1365, 1237, 1092, 913, 780, 763, 726, 684; 1H NMR (400 MHz,
CDCl3): δ 8.03−8.00 (m, 4H), 7.58−7.49 (m, 6H), 1.33 (s, 9H);
13C{1H} NMR (101 MHz, CDCl3): δ 157.3, 140.1 (2C), 133.3 (2C),
129.5 (4C), 127.9 (4C), 80.8, 28.1 (3C); HRMS (ESI-TOF) m/z:
calcd for C17H20NO3S [M + H ]
+ 318.1164, found 318.1164.
tert-Butyl[ethenyl(oxido)phenyl-λ6-sulfanylidene]carbamate
(2g). Prepared according to General Procedure 1 using sulfoxide 1g
(94 mg, 0.62 mmol) and tert-butylcarbamate (109 mg, 0.930 mmol).
Puriﬁcation by ﬂash chromatography (50% EtOAC/hexane) aﬀorded
N-Boc-sulfoximine 2g (147 mg, 89%) as a white solid. Rf = 0.5 (50%
EtOAc/hexane); mp =83−87 °C; IR (ﬁlm) νmax (cm−1): 3062, 2973,
1655, 1271, 1232, 1151, 1085, 979, 894, 867, 755, 690; 1H NMR (400
MHz, CDCl3): δ 7.95 (app d, J = 7.6 Hz, 2H), 7.64 (t, J = 7.6 Hz, 1H),
7.56 (app t, J = 7.6 Hz, 2H), 6.73 (dd, J = 16.4, 9.6 Hz, 1H), 6.47 (d, J
= 16.4 Hz, 1H), 6.12 (d, J = 9.6 Hz, 1H), 1.38 (s, 9H); 13C{1H} NMR
(101 MHz, CDCl3): δ 157.5, 138.1, 137.3, 133.7, 129.7 (2C), 128.8,
128.0 (2C), 80.9, 28.1 (3C); HRMS (ESI-TOF) m/z: calcd for
C13H18NO3S
+ [M + H]+ 268.1007, found 268.1010.
tert-Butyl[dibenzyl(oxido)-λ6-sulfanylidene]carbamate (2h). Pre-
pared according to General Procedure 1 using sulfoxide 1h (138 mg,
0.60 mmol) and tert-butylcarbamate (105 mg, 0.900 mmol).
Puriﬁcation by ﬂash chromatography (40% hexane/EtOAc) and
recrystallization (Et2O) aﬀorded N-Boc-sulfoximine 2h (137 mg,
66%) as a white solid. Rf = 0.3 (40% hexane/EtOAc); mp =129−131
°C; IR (ﬁlm) νmax (cm
−1): 2984, 1657, 1457, 1365, 1287, 1247, 1146,
912, 771, 697; 1H NMR (400 MHz, CDCl3): δ 7.42−7.38 (m, 10H),
4.55 (d, J = 14 Hz, 2H), 4.48 (d, J = 14 Hz, 2H), 1.52 (s, 9H);
13C{1H} NMR (101 MHz, CDCl3): δ 158.6, 131.4 (4C), 129.5 (2C),
129.2 (4C), 126.9 (2C), 80.5, 56.4 (2C), 28.3 (3C); HRMS (ESI-
TOF) m/z: calcd for C19H24NO3S
+ [M + H]+ 346.1479, found
346.1477.
tert-Butyl(1-oxidotetrahydro-1H-1λ4-thiophen-1-ylidene)-
carbamate (2i). Prepared according to General Procedure 1 using
sulfoxide 1i (70 mg, 0.67 mmol) and tert-butylcarbamate (118 mg,
1.00 mmol). Puriﬁcation by ﬂash chromatography (30% hexane/
EtOAc) aﬀorded N-Boc-sulfoximine 2i (115 mg, 78%) as a yellow oil.
Rf = 0.3 (30% hexane/ethyl acetate); IR (ﬁlm) νmax (cm
−1): 2975,
1651, 1287, 1155, 727; 1H NMR (400 MHz, CDCl3): δ 3.55−3.48 (m,
2H), 3.20 (app. dt, J = 12.6, 6.1 Hz, 2H), 2.16−2.28 (m, 4H), 1.41 (s,
9H); 13C{1H} NMR (101 MHz, CDCl3): δ 159.1, 80.5, 52.8 (2C),
28.1 (3C), 23.5 (2C); HRMS (ESI-TOF) m/z: calcd for
C11H20N2O3NaS
+ [M + CH3CN + Na]
+ 283.1092, found 283.1080.
tert-Butyl[(Z)-methyl(phenyl)-λ4-sulfanylidene]carbamate (2j).
To a suspension of the methyl 4-methylphenyl sulﬁde (98 mg, 0.71
mmol), tert-butylcarbamate (125 mg, 1.06 mmol), MgO (97 mg, 2.4
mmol) and Rh2(OAc)4 (7.0 mg, 2.5 mol %) in CH2Cl2 (6 mL) was
added PhI(OAc)4 (290 mg, 0.900 mmol) at rt. The resulting mixture
was stirred for 8 h at 40 °C. The reaction mixture was ﬁltered through
a pad of diatomaceous earth and concentrated in vacuo. Puriﬁcation by
ﬂash chromatography (EtOAc) aﬀorded N-Boc-sulﬁlimine 2j (61 mg,
34%) as a white solid. Rf = 0.3 (EtOAc); mp =152−155 °C; IR (ﬁlm)
νmax (cm
−1): 3013, 2975, 2925, 1626, 1361, 1277, 1246, 1158, 1079,
985, 835, 817, 786, 753, 1H NMR (400 MHz, CDCl3): δ 7.65 (app d, J
= 8 Hz, 2H), 7.32 (app d, J = 8 Hz, 2H), 2.77 (s, 3H), 2.41 (s, 3H),
1.46 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3): δ 164.6, 143.0,
133.8, 130.6 (2C), 126.3 (2C), 79.0, 36.0, 28.5 (3C), 21.5; HRMS
(ESI-TOF) m/z: calcd for C13H20NO2S [M + H]
+ 254.1215, found
254.1225.
Methyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (3a). Prepared according to General Procedure 1 using
sulfoxide 1a (98 mg, 0.64 mmol) and methyl carbamate (72 mg, 0.96
mmol). Puriﬁcation by ﬂash chromatography (30% hexane/EtOAc)
aﬀorded sulfoximine 3a (142 mg, 98%) as a white solid. Rf = 0.5 (30%
hexane/EtOAc); mp =92−96 °C; IR (ﬁlm) νmax (cm−1): 2952, 1672,
1251, 1226, 1089, 982, 873, 790; 1H NMR (400 MHz, CDCl3): δ 7.84
(app d, J = 8.3 Hz, 2H), 7.37 (app d, J = 8.3 Hz, 2H), 3.63 (s, 3H),
3.27 (s, 3H), 2.43 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
159.5, 145.2, 135.2, 130.4 (2C), 127.4 (2C), 53.2, 44.6, 21.7; HRMS
(ESI-TOF) m/z: calcd for C10H14NO3S
+ [M + H]+ 228.0694, found
228.0703.
Methyl[(chloromethyl)(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (3d). Prepared according to General Procedure 1 using
sulfoxide 1d (123 mg, 0.65 mmol) and methyl carbamate (73 mg, 0.97
mmol). Puriﬁcation by ﬂash chromatography (50% EtOAc/hexane)
aﬀorded sulfoximine 3d (113 mg, 66%) as a white solid. Rf = 0.5 (50%
ethyl acetate/hexane); mp =80−84 °C; IR (ﬁlm) νmax (cm−1): 3017,
2955, 1670, 1439, 1263, 1234, 1192, 1148, 1090, 961, 894, 814, 737;
1H NMR (400 MHz, CDCl3): δ 7.90 (app d, J = 8.3 Hz, 2H), 7.41
(app d, J = 8.3 Hz, 2H), 5.18 (d, J = 11.9 Hz, 1H), 4.84 (d, J = 11.9
Hz, 1H), 3.73 (s, 3H), 2.47 (s, 3H); 13C{1H} NMR (101 MHz,
CDCl3): δ 159.2, 146.5, 130.4 (2C), 130.0, 129.5 (2C), 58.6, 53.7,
21.9; HRMS (ESI-TOF) m/z: calcd for C10H13ClNO3S
+ [M + H]+
262.0305, found 262.0308.
Methyl[ethenyl(oxido)phenyl-λ6-sulfanylidene]carbamate (3g).
Prepared according to General Procedure 1 using sulfoxide 1g (91
mg, 0.60 mmol) and methyl carbamate (67 mg, 0.90 mmol).
Puriﬁcation by ﬂash chromatography (50% EtOAc/hexane) aﬀorded
sulfoximine 3g (106 mg, 78%) as a white solid. Rf = 0.4 (50% EtOAc/
hexane); mp =59−63 °C; IR (ﬁlm) νmax (cm−1): 3062, 2957, 1647,
1438, 1252, 1218, 955, 888, 792, 770, 699, 685; 1H NMR (400 MHz,
CDCl3): δ 7.96 (app d, J = 8.0 Hz, 2H), 7.66 (t, J = 8.0 Hz, 1H), 7.58
(app t, J = 8.0 Hz, 2H), 6.74 (dd, J = 16.3, 9.6 Hz, 1H), 6.51 (d, J =
16.3 Hz, 1H), 6.18 (d, J = 9.6 Hz, 1H), 3.67 (s, 3H); 13C{1H} NMR
(101 MHz, CDCl3): δ 159.3, 137.5, 136.9, 134.0, 129.8 (2C), 129.3,
128.0 (2C), 53.4; HRMS (ESI-TOF) m/z: calcd for C10H12NO3S
+ [M
+ H]+ 226.0538, found 226.0542.
Ethyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]carbamate
(4a). Prepared according to General Procedure 1 using sulfoxide 1a
(101 mg, 0.657 mmol) and ethyl carbamate (87.7 mg, 0.985 mmol).
Puriﬁcation by ﬂash chromatography (30% hexane/EtOAc) aﬀorded
sulfoximine 4a (122 mg, 77%) as a white solid. Rf = 0.4 (30% hexane/
EtOAc); mp =57−61 °C; IR (ﬁlm) νmax (cm−1): 3018, 2988, 2930,
1664, 1592, 1467, 1412, 1368, 1244, 1219, 1085, 986, 872, 790, 766;
1H NMR (400 MHz, CDCl3): δ 7.86 (app d, J = 8.2 Hz, 2H), 7.38
(app d, J = 8.2 Hz, 2H), 4.14−4.02 (m, 2H), 3.28 (s, 3H), 2.45 (s,
3H), 1.22 (t, J = 7.2 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
159.1, 145.2, 135.4, 130.4 (2C), 127.5 (2C), 62.0, 44.8, 21.7, 14.4;
HRMS (ESI-TOF) m/z: calcd for C11H16NO3S
+ [M + H]+ 242.0851,
found 242.0850. Compound previously reported.46
Ethyl[dibenzyl(oxido)-λ6-sulfanylidene]carbamate (4h). Prepared
according to General Procedure 1 using sulfoxide 1h (139 mg, 0.604
mmol) and ethyl carbamate (80.7 mg, 0.906 mmol). Puriﬁcation by
ﬂash chromatography (30% EtOAc/hexane) aﬀorded sulfoximine 4h
(145 mg, 76%) as a white solid. Rf = 0.3 (30% EtOAc/hexane); mp
=98−102 °C; IR (ﬁlm) νmax (cm−1): 3065, 2974, 2940, 1646, 1456,
1365, 1273, 1233, 1109, 1003, 905, 785, 695; 1H NMR (400 MHz,
CDCl3): δ 7.46−7.33 (m, 10H), 4.56 (d, J = 14.0 Hz, 2H), 4.51 (d, J =
14.0 Hz, 2H), 4.17 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 159.4, 131.4 (4C), 129.6 (2C),
129.2 (4C), 126.6 (2C), 62.3, 56.6 (2C), 14.6; HRMS (ESI-TOF) m/
z: calcd for C17H20NO3S
+ [M + H]+ 318.1164, found 318.1172.
The Journal of Organic Chemistry Article
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tert-Butyl(1-oxido-1λ4-thietan-1-ylidene)carbamate (9). Prepared
according to General Procedure 1 using sulfoxide 8 (70 mg, 0.78
mmol) and tert-butylcarbamate (137 mg, 1.17 mmol). Puriﬁcation by
ﬂash chromatography (30% hexane/EtOAc) aﬀorded N-Boc-sulfox-
imine 9 (136 mg, 85%) as a white solid. Rf = 0.3 (30% hexane/
EtOAc); mp =76−80 °C; IR (ﬁlm) νmax (cm−1): 1645, 1281, 1152,
843, 715; 1H NMR (400 MHz, CDCl3): δ 4.39−4.32 (m, 2H), 4.24−
4.15 (m, 2H), 2.45−2.36 (m, 2H), 1.49 (s, 9H); 13C{1H} NMR (101
MHz, CDCl3): δ 158.7, 81.2, 62.8 (2C), 28.2 (3C), 9.7; HRMS (ESI-
TOF) m/z: calcd for C10H18N2O3NaS
+ [M + CH3CN + Na]
+
269.0936, found 269.0934.
Methyl(1-oxido-1λ4-thietan-1-ylidene)carbamate (10). Prepared
according to General Procedure 1 using sulfoxide 8 (70 mg, 0.77
mmol) and methyl carbamate (86.7 mg, 1.15 mmol). Puriﬁcation by
ﬂash chromatography (EtOAc) aﬀorded sulfoximine 10 (104 mg,
83%) as a colorless gum. Rf = 0.4 (EtOAc); IR (ﬁlm) νmax (cm
−1):
2956, 1655, 1437, 1230, 995, 879, 788; 1H NMR (400 MHz, CDCl3):
δ 4.40−4.33 (m, 2H), 4.27−4.19 (m, 2H), 3.71 (s, 3H), 2.39 (app. tt, J
= 7.8, 4.2 Hz, 2H); 13C{1H} NMR (101 MHz, CDCl3): δ 160.1, 63.0
(2C), 53.4, 9.6; HRMS (ESI-TOF) m/z: calcd for C5H10NO3S
+ [M +
H]+ 164.0381, found 164.0376.
Ethyl(1-oxido-1λ4-thietan-1-ylidene)carbamate (11). Prepared
according to General Procedure 1 using sulfoxide 8 (59 mg, 0.66
mmol) and ethyl carbamate (87.5 mg, 0.982 mmol). Puriﬁcation by
ﬂash chromatography (30% hexane/EtOAc) aﬀorded sulfoximine 11
(90 mg, 78%) as a colorless gum. Rf = 0.3 (30% hexane/EtOAc); IR
(ﬁlm) νmax (cm
−1): 2980, 1651, 1367, 1266, 1227, 1171, 1012, 931,
870, 788; 1H NMR (400 MHz, CDCl3): δ 4.44−4.32 (m, 2H), 4.27−
4.17 (m, 2H), 4.15 (q, J = 7.1 Hz, 2H), 2.40 (app. dq, J = 9.4, 7.1 Hz,
2H), 1.28 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
159.6, 63.0, 62.4 (2C), 14.5, 9.6; HRMS (ESI-TOF) m/z: calcd for
C6H12NO3S
+ [M+H ]+ 178.0538, found 178.0534.
Preparation of N-Cbz, N-CO2Ph and N-Allyl sulfoximines (5,
6, 7, 12, 13, 14). General Procedure 2 To a suspension of the
sulfoxide (0.6 mmol), carbamate (0.9 mmol), MgO (97 mg, 2.4
mmol) and Rh2(OAc)4 (7.0 mg, 2.5 mol %) in CH2Cl2 (2 mL) was
added PhI(OAc)2 (290 mg, 0.90 mmol) at rt. The resulting mixture
was stirred for 8 h at 40 °C. The reaction mixture was ﬁltered through
a pad of diatomaceous earth and concentrated in vacuo and the
resulting residue was puriﬁed by ﬂash chromatography to give the N-
substituted sulfoximine.
Benzyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (5a). Prepared according to General Procedure 2 using
sulfoxide 1a (58.4 mg, 0.379 mmol) and benzyl carbamate (86 mg,
0.57 mmol). Puriﬁcation by ﬂash chromatography (50% EtOAc/
hexane) aﬀorded N-Cbz-sulfoximine 5a (69 mg, 60%) as a white solid.
Rf = 0.4 (50% EtOAc/hexane); mp =90−94 °C; IR (ﬁlm) νmax (cm−1):
3026, 2927, 1657, 1218, 1087, 780, 694; 1H NMR (400 MHz,
CDCl3): δ 7.84 (app d, J = 8.0 Hz, 2H), 7.37 (app d, J = 8.0 Hz, 2H),
7.33−7.22 (m, 5H), 5.12 (d, J = 12.0 Hz, 1H), 5.03 (d, J = 12.0 Hz,
1H), 3.28 (s, 3H), 2.45 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ
158.8, 145.2, 136.3, 135.3, 130.4 (2C), 128.5 (2C), 128.3 (2C), 128.1,
127.5 (2C), 67.9, 44.8, 21.7; HRMS (ESI-TOF) m/z: calcd for
C16H18NO3S
+ [M + H]+ 304.1007, found 304.0999.
Benzyl[(4-chlorophenyl)(ethyl)oxido-λ6-sulfanylidene]carbamate
(5b). Prepared according to General Procedure 2 using sulfoxide 1b
(215 mg, 1.14 mmol) and benzyl carbamate (258 mg, 1.71 mmol),
with a reaction time of 24 h. Puriﬁcation twice by ﬂash
chromatography (50% EtOAc/hexane) and (30% hexane/Et2O)
aﬀorded N-Cbz-sulfoximine 5b (199 mg, 52%) as a white solid. The
second ﬂash chromatography was necessary to remove excess benzyl
carbamate. Rf = 0.5 (50% EtOAc/hexane), 0.3 (30% hexane/Et2O);
mp =70−73 °C. IR (ﬁlm) νmax (cm−1): 2942, 1665, 1576, 1455, 1377,
1237, 1086, 901, 783, 727, 697; 1H NMR (400 MHz, CDCl3): δ 7.83
(app. dt, J = 8.8, 2.3 Hz, 2H), 7.53 (app. dt, J = 8.8, 2.3 Hz, 2H), 7.31−
7.25 (m, 5H), 5.12 (d, J = 12.2 Hz, 1H), 5.00 (d, J = 12.2 Hz, 1H),
3.50−3.31 (m, 2H), 1.27 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (101
MHz, CDCl3): δ 158.5, 140.9, 136.2, 134.8, 130.1 (2C), 129.7 (2C),
128.5 (2C), 128.4 (2C), 128.1, 68.0, 50.9, 7.0; HRMS (ESI-TOF) m/
z: calcd for C16H17ClNO3S
+ [M + H]+ 338.0618, found 338.0613.
Benzyl[ethenyl(oxido)phenyl-λ6-sulfanylidene]carbamate (5g).
Prepared according to General Procedure 2 using sulfoxide 1g (96
mg, 0.63 mmol) and benzyl carbamate (143 mg, 0.945 mmol).
Puriﬁcation by ﬂash chromatography (30% hexane/Et2O) yielded a
white solid, which was washed with Et2O to remove unreacted
sulfoxide aﬀording N-Cbz-sulfoximine 5g (74 mg, 40%) as a white
solid. Rf = 0.3 (30% hexane/Et2O); mp =63−66 °C; IR (ﬁlm) νmax
(cm−1): 3067, 1653, 1449, 1382, 1243, 1220, 1082, 961, 898, 753, 689;
1H NMR (400 MHz, CDCl3): δ 7.95 (app d, J = 7.4 Hz, 2H), 7.65 (t, J
= 7.4 Hz, 1H), 7.56 (app t, J = 7.7 Hz, 2H), 7.32−7.27 (m, 5H), 6.74
(dd, J = 16.4, 9.6 Hz, 1H), 6.51 (d, J = 16.4 Hz, 1H), 6.16 (d, J = 9.6,
Hz, 1H), 5.12 (d, J = 12.3 Hz, 1H), 5.07 (d, J = 12.3 Hz, 1H); 13C{1H}
NMR (101 MHz, CDCl3): δ 158.5, 137.5, 136.9, 136.3, 134.0, 129.8
(2C), 129.4, 128.5 (2C), 128.4 (2C), 128.1, 128.0 (2C), 68.1; HRMS
(ESI-TOF) m/z: calcd for C16H16NO3S
+ [M + H]+ 302.0851, found
302.0859.
Phenyl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (6a). Prepared according to General Procedure 2 using
sulfoxide 1a (103 mg, 0.67 mmol) and phenyl carbamate (138 mg,
1.01 mmol). Puriﬁcation by ﬂash chromatography (50% hexane/
EtOAc) aﬀorded sulfoximine 6a (96 mg, 54%) as a white solid. Rf =
0.5 (50% hexane/EtOAc); mp =110−116 °C; IR (ﬁlm) νmax (cm−1):
3044, 2939, 1671, 1261, 1222, 1177, 1093, 975, 808, 780, 715; 1H
NMR (400 MHz, CDCl3) δ: 7.92 (app d, J = 8.3 Hz, 2H), 7.42 (app d,
J = 8.3 Hz, 2H), 7.31 (t, J = 8.0 Hz, 2H), 7.17−7.11 (m, 3H), 3.38 (s,
3H), 2.47 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 157.5, 151.6,
145.5, 134.8, 130.6 (2C), 129.3 (2C), 127.5 (2C), 125.4, 121.8 (2C),
44.7, 21.8; HRMS (ESI-TOF) m/z: calcd for C15H16NO3S
+ [M + H]+
290.0851, found 290.0863.
Phenyl[dibenzyl(oxido)-λ6-sulfanylidene]carbamate (6h). Pre-
pared according to General Procedure 2 using sulfoxide 1h (138
mg, 0.600 mmol) and phenyl carbamate (123 mg, 0.900 mmol).
Puriﬁcation by ﬂash chromatography (40% EtOAc/hexane) aﬀorded
sulfoximine 6h (86 mg, 40%) as a yellow oil. Rf = 0.5 (40% EtOAc/
hexane); IR (ﬁlm) νmax (cm
−1): 3063, 2981, 1775, 1668, 1483, 1275,
1180, 1071, 920, 881, 761, 695; 1H NMR (400 MHz, CDCl3): δ 7.49−
7.34 (m, 12H), 7.25−7.19 (m, 1H), 7.14 (dd, J = 8.5, 1.0 Hz, 2H),
4.65 (d, J = 13.8 Hz, 2H), 4.56 (d, J = 13.8 Hz, 2H); 13C{1H} NMR
(101 MHz, CDCl3): δ 158.0, 151.8, 131.5 (4C), 131.0, 129.8 (2C),
129.4 (2C), 129.3 (4C), 126.2 (2C), 125.6, 121.9 (2C), 56.6 (2C);
HRMS (ESI-TOF) m/z: calcd for C21H20NO3S
+ [M + H]+ 366.1164,
found 366.1157.
Prop-2-en-1-yl[methyl(4-methylphenyl)oxido-λ6-sulfanylidene]-
carbamate (7a). Prepared according to General Procedure 2 using
sulfoxide 1a (107 mg, 0.695 mmol) and allyl carbamate (105 mg,
1.042 mmol). Puriﬁcation by ﬂash chromatography (40% EtOAc/
hexane) aﬀorded sulfoximine 7a (70 mg, 40%) as a white solid. Rf =
0.3 (40% EtOAc/hexane); mp =55−58 °C; IR (ﬁlm) νmax (cm−1):
2929, 1668, 1226, 1089, 975, 872, 788; 1H NMR (400 MHz, CDCl3):
δ 7.86 (app d, J = 8.3 Hz, 2H), 7.39 (app d, J = 8.3 Hz, 2H), 5.94−5.84
(m, 1H), 5.27 (dd, J = 17.2, 1.3 Hz, 1H), 5.17 (dd, J = 10.4, 1.3 Hz,
1H), 4.57−4.48 (m, 2H), 3.28 (s, 3H), 2.45 (s, 3H); 13C{1H} NMR
(101 MHz, CDCl3): δ 158.8, 145.2, 135.3, 132.6, 130.5 (2C), 127.5
(2C), 118.0, 66.8, 44.8, 21.7; HRMS (ESI-TOF) m/z: calcd for
C12H16NO3S
+ [M + H]+ 254.0851, found 254.0854.
Prop-2-en-1-yl[(4-chlorophenyl)(ethyl)oxido-λ6-sulfanylidene]-
carbamate (7b). Prepared according to General Procedure 2 using
sulfoxide 1b (115 mg, 0.61 mmol) and allyl carbamate (92.5 mg, 0.915
mmol). Puriﬁcation by ﬂash chromatography (30% hexane/Et2O)
aﬀorded sulfoximine 7b (65 mg, 38%) as a white solid. Rf = 0.3 (30%
hexane/Et2O); mp =49−53 °C; IR (ﬁlm) νmax (cm−1): 3089, 2941,
1668, 1578, 1360, 1236, 1086, 965, 876, 785; 1H NMR (400 MHz,
CDCl3): δ 7.87 (app d, J = 8.7 Hz, 2H), 7.58 (app d, J = 8.7 Hz, 2H),
5.93−5.83 (m, 1H), 5.27 (dd, J = 17.4, 1.4 Hz, 1H), 5.18 (dd, J = 10.3,
1.4 Hz, 1H), 4.59−4.47 (m, 2H), 3.51−3.31 (m, 2H), 1.28 (t, J = 7.4
Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 158.6, 141.0, 134.7,
132.5, 130.1 (2C), 129.8 (2C), 118.2, 67.0, 50.9, 7.0; HRMS (ESI-
TOF) m/z: calcd for C12H15ClNO3S
+ [M + H]+ 288.0461, found
288.0464.
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Benzyl(1-oxido-1λ4-thietan-1-ylidene)carbamate (12). Prepared
according to General Procedure 2 using sulfoxide 8 (55.3 mg, 0.614
mmol) and benzyl carbamate (139 mg, 0.921 mmol). Puriﬁcation by
ﬂash chromatography (20% hexane/EtOAc) aﬀorded N-Cbz-sulfox-
imine 12 (101 mg, 70%) as a colorless gum. Rf = 0.3 (20% hexane/
EtOAc); IR (ﬁlm) νmax (cm
−1): 3033, 2961, 1702, 1653, 1378, 1228,
990, 889, 734, 698; 1H NMR (400 MHz, CDCl3): δ 7.40−7.28 (m,
5H), 5.15 (s, 2H), 4.41−4.33 (m, 2H), 4.26−4.18 (m, 2H), 2.42−2.34
(m, 2H); 13C{1H} NMR (101 MHz, CDCl3): δ 159.4, 136.2, 128.6
(2C), 128.3 (2C), 128.2, 68.2, 63.1 (2C), 9.6; HRMS (ESI-TOF) m/z:
calcd for C11H14NO3S
+ [M + H]+ 240.0694, found 240.0693.
Phenyl(1-oxido-1λ4-thietan-1-ylidene)carbamate (13). Prepared
according to General Procedure 2 using sulfoxide 8 (61 mg, 0.68
mmol) and phenyl carbamate (140 mg, 1.02 mmol). Puriﬁcation by
ﬂash chromatography (30% hexane/EtOAc) aﬀorded sulfoximine 13
(69 mg, 50%) as a white solid. Rf = 0.3 (30% hexane/EtOAc); mp
=121−125 °C; IR (ﬁlm) νmax (cm−1): 3044, 2973, 1666, 1495, 1267,
1241, 1180, 884, 773, 705, 687; 1H NMR (400 MHz, CDCl3): δ 7.36
(t, J = 8 Hz 2H), 7.22−7.18 (m, 3H), 4.52−4.44 (m, 2H), 4.31−4.23
(m, 2H), 2.52−2.36 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3): δ
158.2, 151.5, 129.4 (2C), 125.7, 121.7 (2C), 63.1 (2C), 9.5; HRMS
(ESI-TOF) m/z: calcd for C10H12NO3S
+ [M + H]+ 226.0536, found
226.0532.
Prop-2-en-1-yl(1-oxido-1λ4-thietan-1-ylidene)carbamate (14).
Prepared according to General Procedure 2 starting from sulfoxide
8 (69 mg, 0.77 mmol) and allyl carbamate (117 mg, 1.16 mmol).
Puriﬁcation by ﬂash chromatography (40% hexane/EtOAc) aﬀorded
sulfoximine 14 (60 mg, 45%) as a yellow oil. Rf = 0.3 (40% hexane/
EtOAc); IR (ﬁlm) νmax (cm
−1): 2959, 1656, 1228, 990, 875, 787. 1H
NMR (400 MHz, CDCl3): δ 6.01−5.90 (m, 1H), 5.34 (d, J = 17.2 Hz,
1H), 5.23 (d, J = 10.4 Hz, 1H), 4.61 (d, J = 5.7 Hz, 2H), 4.45−4.35
(m, 2H), 4.30−4.19 (m, 2H), 2.49−2.36 (m, 2H); 13C{1H} NMR
(101 MHz, CDCl3): δ 159.3, 132.4, 118,3, 67.2, 63.1 (2C), 9.6; HRMS
(ESI-TOF) m/z: calcd for C7H12NO3S
+ [M + H]+ 190.0538, found
190.0539.
Cross Coupling Reactions. The Suzuki cross coupling reactions
were carried out according to previously reported reaction
conditions,32b modiﬁed from conditions developed by Buchwald.35
Conditions developed by Fürstner were used for the Fe-catalyzed cross
coupling.37
tert-Butyl[biphenyl-4-yl(ethyl)oxido-λ6-sulfanylidene]carbamate
(15). Phenylboronic acid (21 mg, 0.17 mmol), aryl chloride 2b (40 mg,
0.13 mmol), Pd(OAc)2 (1.5 mg, 0.0066 mmol), SPhos (5.4 mg, 0.013
mmol) and K2CO3 (37 mg, 0.26 mmol) were dissolved in 1,4-
dioxane/water (1.5 mL, 4:1) under N2. The reaction mixture was
stirred at 65 °C for 3.5 h, the reaction mixture was cooled to rt and
ﬁltered through a plug of diatomaceous earth. The solvent was
removed in vacuo and the crude residue puriﬁed by silica gel ﬂash
column chromatography (30% EtOAc in pentane) to yield the product
as a white solid (36 mg, 79%). Rf = 0.20 (30% EtOAc in pentane); mp
=68−70 °C; IR (ﬁlm) νmax (cm−1): 2977, 1663, 1593, 1480, 1365,
1269, 1248, 1153 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.01−7.95
(m, 2H), 7.81−7.75 (m, 2H), 7.64−7.58 (m, 2H), 7.52−7.45 (m, 2H),
7.45−7.40 (m, 1H), 3.38 (m, 2H), 1.38 (s, 9H), 1.28 (t, J = 7.4 Hz,
3H); 13C{1H} NMR (101 MHz, CDCl3): δ 158.0, 146.7, 139.1, 135.1,
129.2 (2C), 128.8 (3C), 128.2 (2C), 127.5 (2C), 80.6, 51.0, 28.1
(3C), 7.0; HRMS: (ESI-TOF) m/z: calcd for C21H26N2O3SNa [M +
MeCN + Na]+ 409.1559, found 409.1569.
Benzyl[biphenyl-4-yl(ethyl)oxido-λ6-sulfanylidene]carbamate
(16). Reaction carried out according to the same procedure as with
Boc-protected example (2b) using aryl chloride 5b (45 mg, 0.13
mmol), Pd(OAc)2 (1.5 mg, 0.0066 mmol), SPhos (5.4 mg, 0.013
mmol) and K2CO3 (37 mg, 0.26 mmol) in 1,4-dioxane/water (1.5 mL,
4:1). The crude product was puriﬁed by silica gel ﬂash chromatog-
raphy (5:4:1, pentane/Et2O/acetone) to yield the product as a white
solid (27 mg, 54%). Rf = 0.21 (5:4:1, pentane/Et2O/acetone); mp
=104−105 °C; IR (ﬁlm) νmax (cm−1): 2940, 1668, 1592, 1480, 1455,
1236, 1090 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.97 (app d, J = 8.5
Hz, 2H), 7.76 (app d, J = 8.5 Hz, 2H), 7.64−7.58 (m, 2H), 7.55−7.41
(m, 3H), 7.37−7.20 (m, 5H), 5.14 (d, J = 12.0 Hz, 1H), 5.03 (d, J =
12.3 Hz, 1H), 3.55−3.33 (m, 2H), 1.30 (t, J = 7.4 Hz, 3H); 13C{1H}
NMR (101 MHz, CDCl3): δ 158.8, 147.0, 139.1, 136.4, 134.6, 129.2
(2C), 128.9, 128.8 (2C), 128.4 (2C), 128.3 (4C), 128.0, 127.5 (2C),
67.9, 51.1, 7.1; HRMS: (ESI-TOF) m/z: calcd for C22H22NO3S [M +
H]+ 380.1320, found 380.1332.
tert-Butyl[(4-hexylphenyl)(ethyl)oxido-λ6-sulfanylidene]-
carbamate (17). n-Hexylmagnesium bromide (79 μL, 2.0 M in Et2O,
0.16 mmol) was added to a solution of aryl chloride 2b (40 mg, 0.13
mmol) and Fe(acac)3 (2.3 mg, 0.0066 mmol) in THF/NMP (1.3 mL,
9:1) at rt. The reaction was stirred for 15 min, diluted with Et2O (3
mL) and quenched with 1 M HCl (3 mL). The aqueous layer was
separated, extracted with Et2O (2 × 5 mL) and the combined organic
fractions were dried over anhydrous MgSO4. The solvent was removed
in vacuo, and the resulting residue was puriﬁed by silica gel ﬂash
column chromatography (1:1, pentane/EtOAc) to yield the product as
a colorless oil (36 mg, 63%). Rf = 0.23 (30% EtOAc in pentane); IR
(ﬁlm) νmax (cm
−1): 2929, 2858, 1693, 1665, 1456, 1365, 1271, 1249,
1217, 1156, 1107, 1088 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.84−
7.75 (m, 2H), 7.40−7.33 (m, 2H), 3.32 (m, 2H), 2.72−2.63 (m, 2H),
1.62 (quintet, J = 7.5 Hz, 2H), 1.41−1.16 (m, 18H), 0.86 (s, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 157.9, 149.6, 133.7, 129.6,
128.3, 80.4, 50.9, 36.0, 31.7, 31.1, 29.8, 29.0, 28.1, 22.6, 14.1, 7.0;
HRMS: (ESI-TOF) m/z: calcd for C19H32NO3S [M + H]
+ 354.2103,
found 354.2112.
Benzyl[(4-hexylphenyl)(ethyl)oxido-λ6-sulfanylidene]carbamate
(18). Reaction carried out according to the same procedure as with
Boc-protected example (2b) using nhexylmagnesium bromide (43 μL,
2.0 M in Et2O, 0.086 mmol), aryl chloride 5b (24 mg, 0.070 mmol)
and Fe(acac)3 (2.3 mg, 0.0034 mmol) in THF/NMP (0.7 mL, 9:1).
The crude product was puriﬁed by silica gel ﬂash chromatography
(5:4:1, pentane/Et2O/acetone) to yield the product as a colorless oil
(17 mg, 63%). Rf = 0.36 (5:4:1, pentane/Et2O/acetone); IR (ﬁlm)
νmax (cm
−1): 2929, 1673, 1456, 1378, 1245, 1089 cm−1; 1H NMR (400
MHz, CDCl3): δ 7.80 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.4 Hz, 2H),
7.30−7.26 (m, 4H), 5.11 (d, J = 12.3 Hz, 1H), 5.02 (d, J = 12.3 Hz,
1H), 3.49−3.30 (m, 2H), 2.73−2.64 (m, 2H), 1.70−1.56 (m, 2H),
1.38−1.28 (m, 6H), 1.25 (t, J = 7.4 Hz, 3H), 0.93−0.84 (m, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 158.85, 150.0, 136.5, 133.1,
129.7 (2C), 128.4 (2C), 128.3 (4C), 128.0, 67.8, 51.0, 36.1, 31.7, 31.1,
29.1, 22.7, 14.2, 7.1; HRMS: (ESI-TOF) m/z: calcd for C22H30NO3S
[M + H]+ 388.1946, found 388.1934.
Deprotection of Sulfoximine Carbamates 2a and 5a. 1-
Methyl-4-(S-methylsulfonimidoyl)benzene (19). From 2a: Boc-
protected sulfoximine 2a (50 mg, 0.19 mmol) was dissolved in
CH2Cl2 (0.30 mL) in a 10 mL round-bottom ﬂask. Triﬂuoroacetic acid
(0.10 mL, 1.31 mmol) was added dropwise, and the reaction mixture
was stirred at rt for 1 h, diluted with H2O (3 mL) and quenched with
NaHCO3 (solid, 250 mg). The organic layer was separated and the
aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The combined
organic layers were dried over anhydrous Na2SO4 and the solvent
removed in vacuo. The resulting oil was puriﬁed by silica gel ﬂash
column chromatography (EtOAc) to yield the product as a white solid
(31 mg, 98%). From 5a: Cbz-protected sulfoximine 5a (50 mg, 0.19
mmol) and Pd/C (17.5 mg, 0.19 mmol) were suspended in EtOH (1.5
mL) and stirred under 1 atm of H2 (balloon) for 1 h. The reaction
mixture was ﬁltered through a plug of diatomaceous earth, washed
with MeOH (2 × 3 mL) and the solvent was removed in vacuo. The
resulting oil was puriﬁed by silica gel ﬂash column chromatography
(EtOAc) to yield the product as a white solid (21 mg, 77%). Rf = 0.18
(EtOAc); mp =69−70 °C; IR (ﬁlm) νmax (cm−1): 3273, 2924, 1597,
1408, 1216, 1093 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.91−7.83
(m, 2H), 7.33 (app d, J = 8.2 Hz, 2H), 3.07 (s, 3H), 2.65 (s, 1H), 2.43
(s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 144.0, 140.7, 130.0,
127.8, 46.43, 21.6; HRMS: (ESI-TOF) m/z: calcd for C8H12NOS [M
+ H]+ 170.0640, found 170.0640. Analytical data in agreement with
those reported in the literature.47
1λ4-Thietan-1-imine 1-oxide (20). TFA (0.15 mL, 1.95 mmol) was
added dropwise to a solution of Boc-protected sulfoximine 9 (40 mg,
0.20 mmol) in CH2Cl2 (1.0 mL) and the reaction was stirred at rt for 2
h. The volatiles were removed in vacuo by azeotropic distillation with
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b00844
J. Org. Chem. 2015, 80, 6391−6399
6397
D
ow
nl
oa
de
d 
by
 IM
PE
RI
A
L 
CO
LL
EG
E 
LO
N
D
O
N
 o
n 
A
ug
us
t 2
7,
 2
01
5 
| ht
tp:
//p
ubs
.ac
s.o
rg 
 
Pu
bl
ic
at
io
n 
D
at
e 
(W
eb
): 
Ju
ne
 2,
 20
15
 | d
oi:
 10
.10
21/
acs
.jo
c.5
b00
844
toluene. The crude residue was dissolved in H2O (1 mL) and
neutralized with saturated aqueous Na2CO3 (2 mL). The aqueous
layer was extracted with CH2Cl2 several times until no further product
was present, as judged by TLC analysis. The combined organic layers
were dried over anhydrous Na2SO4 and the solvent was removed in
vacuo (35 °C, 700 mbar). The crude residue was puriﬁed by silica gel
ﬂash column chromatography (30% acetone in EtOAc) to yield the
product as a pale yellow oil (14.2 mg, 69%). The solvent from the
combined product fractions was removed by azeotropic distillation
with Et2O (35 °C, 50 mbar) due to the volatility of the product. Rf =
0.26 (30% acetone in EtOAc); IR (ﬁlm) νmax (cm
−1): 3257, 1652,
1401, 1231, 1205, 1167, 1016 cm−1; 1H NMR (400 MHz, CDCl3): δ
4.17−3.97 (m, 4H), 2.87 (br s, 1H), 2.29−2.13 (m, 2H); 13C{1H}
NMR (101 MHz, CDCl3): δ 66.6 (2C), 7.7; HRMS: (ESI-TOF) m/z:
calcd for C3H7NOS [M + H]
+ 105.0248, found 105.0254.
MSO Synthesis. Compound 21 (Scheme 7) was prepared as
previously reported from N-Boc-L-methionine via compound 23:48,49
(S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-4-(methylthio)-
butanoate (23). N,N′-Dicyclohexylcarbodiimide (DCC, 2.15 g, 10.4
mmol) was added to a cooled solution (0 °C) of N-Boc-L-methionine
(2.00 g, 8.02 mmol), DMAP (80 mg, 0.67 mmol) and tert-butanol
(0.91 mL, 9.6 mmol) in CH2Cl2 (20 mL) and the reaction was stirred
at 0 °C for 2 h. The reaction mixture was allowed to warm to rt and
stirred overnight. The dicyclohexylurea precipitate was ﬁltered oﬀ and
washed with CH2Cl2 (2 × 10 mL). The ﬁltrate was washed with 1 M
HCl (2 × 5 mL) and dried over anhydrous Na2SO4. The solvent was
removed in vacuo and the crude residue was puriﬁed by silica gel ﬂash
column chromatography (20% Et2O in pentane) to yield the product
as a colorless oil (2.18 g, 89%). 1H NMR (400 MHz, CDCl3): δ 5.13
(app. d, J = 8.3 Hz, 1H), 4.30 (app. q, J = 7.1 Hz, 1H), 2.63−2.46 (m,
2H), 2.13 (s, 3H), 2.19−2.07 (m, 1H), 1.92 (m, 1H), 1.48 (app. d, J =
10.4 Hz, 18H); 13C{1H} NMR (101 MHz, CDCl3): δ 171.4, 155.3,
82.2, 79.8, 53.4, 32.6, 29.9, 28.3, 28.0, 15.5. All other spectral data were
in agreement with those previously reported.48
(2S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-4-(methylsulﬁnyl)-
butanoate (21). mCPBA (≤77%,1.85 g, 8.27 mmol) in CH2Cl2 (10
mL) was added dropwise to a stirred solution of sulﬁde 23 (2.11 g,
6.89 mmol) in CH2Cl2 (10 mL) at 0 °C. The reaction mixture was
allowed to warm to room temperature and was stirred for 1 h. The
solvent was removed in vacuo the crude residue was puriﬁed by silica
gel column chromatography (20% acetone in EtOAc) to yield
sulfoxide 21 as a pale yellow oil (1.804 g, 81% as a mixture of
diastereomers (denoted A and B). 1H NMR (400 MHz, CDCl3): δ
5.26 (app. t, J = 9.6 Hz, 1H), 4.38−4.24 (m, 1H), 2.89−2.66 (m, 2H),
2.60 (s, 3H), 2.42−2.28 (m, 1H), 2.15−1.98 (m, 1H), 1.50 (app. d, J =
1.3 Hz, 9H), 1.46 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3): δ
170.7, 155.5, 82.9 (A), 82.8 (B), 80.1, 53.28 (A), 52.88 (B), 50.82 (A),
50.54 (B), 38.75 (A), 38.65 (B), 28.30, 27.99, 26.79 (A), 26.28 (B). All
other spectral data were in agreement with those previously
reported.49
tert-Butyl (2S)-2-[(tert-butoxycarbonyl)amino]-4-[N-(tert-butoxy-
carbonyl)-S-methylsulfonimidoyl]-butanoate (22). Prepared accord-
ing to General Procedure 1, heating for 24 h, using sulfoxide 21 (500
mg, 1.55 mmol) and tert-butylcarbamate (272 mg, 2.32 mmol).
Puriﬁcation by ﬂash chromatography (40% EtOAc/hexane) aﬀorded
N-Boc sulfoximine 22 (557 mg, 82%) as a white solid and as a mixture
of diastereoisomers: Rf = 0.3 (40% EtOAc/hexane); mp =53−57 °C;
IR (ﬁlm) νmax (cm
−1): 3359, 2978, 1711, 1664, 1513, 1366,1278, 1248,
1148, 970, 860, 790; 1H NMR (400 MHz, CDCl3): δ 5.20 (s, br 1H),
4.31−4.18 (m, 1H), 3.54−3.33 (m, 2H), 3.22−3.19 (2 × s, 3H), 2.46−
2.38 (m, 1H), 2.22−2.07 (m, 1H), 1.48 (s, 18H), 1.14 (s, 9H); 1H
NMR (400 MHz, DMSO, 383 K) δ 6.72 (s, 1H), 4.00 (td, J = 8.2, 5.5
Hz, 1H), 3.57−3.33 (m, 2H), 3.23−3.20 (2 × s, 3H), 2.24−2.13 (m,
1H), 2.13−2.01 (m, 1H), 1.44 (app. d, J = 0.8 Hz, 9H), 1.41 (s, 9H),
1.40 (s, 9H); 13C{1H} NMR (101 MHz, CDCl3): δ 170.1, 158.5,
155.5, 83.4, 80.7, 80.5, 52.6, 50.7, 50.6, 39.6, 28.4 (3C), 28.2 (3C),
28.1 (3C), 26.4, 26.3; 13C{1H} NMR (101 MHz, DMSO, 383 K) δ
169.7, 156.7, 154.6, 80.6, 78.0, 52.7, 52.7, 50.2, 50.2, 39.0, 39.0, 27.6
(3C), 27.4 (3C), 27.2 (3C), 23.8, 23.7. HRMS (ESI-TOF) m/z: calcd
for C19H37N2O7S
+ [M + H]+ 437.2321; found 437.2326.
Methionine Sulfoximine (MSO). Protected MSO 22 (200 mg,
0.458 mmol) was dissolved in concentrated HCl (37%, 4.6 mL, 56
mmol) and stirred at 80 °C for 3 h. The conc. HCl was removed in
vacuo with azeotropic distillation in toluene and then MeOH. The
resulting viscous yellow oil was puriﬁed using a Varian Bond Elut SCX
ion-exchange column. The crude product was dissolved in MeOH,
loaded onto the column and ﬂushed with MeOH (3 × column
volumes). The column was then eluted with 3% NH4OH in MeOH (2
× column volumes) to run oﬀ the product. The solvent was removed
to yield MSO as a white solid (85 mg, 66%). 1H NMR (400 MHz,
D2O): δ 3.93−3.82 (m, 1H), 3.58−3.31 (m, 2H), 3.15 (s, 3H), 2.46−
2.27 (m, 2H); 13C{1H} NMR (101 MHz, D2O): δ 172.9, 52.99 (A)
52.95 (B), 52.0, 41.1, 24.2 (A), 24.1 (B). (diastereoisomers denoted A
and B). All other spectral data were in agreement with those previously
reported.38
■ ASSOCIATED CONTENT
*S Supporting Information
1H and 13C{1H} NMR spectra for new compounds (PDF) and
HPLC data for racemic and enantioenriched (1a, 2a, 19). The
Supporting Information is available free of charge on the ACS
Publications website at DOI: 10.1021/acs.joc.5b00844.
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: renzo.luisi@uniba.it.
*E-mail: j.bull@imperial.ac.uk.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
For ﬁnancial support we gratefully acknowledge the EPSRC
(Career Acceleration Fellowship to J.A.B., EP/J001538/1, and
Impact Acceleration Account, EP/K503733/1), the Royal
Society for a Research Grant (R12014, RG130648) and
Imperial College London. We also thank Regione Puglia:
“Reti di Laboratori pubblici di ricerca” Project code 20, Project
Laboratorio Sistema code PONa300369 ﬁnanced by MIUR, the
University of Bari for ﬁnancial support.
■ REFERENCES
(1) (a) Johnson, C. R. Aldrichimica Acta 1985, 18, 3. (b) Reggelin,
M.; Zur, C. Synthesis. 2000, 1. (c) Bizet, V.; Kowalczyk, R.; Bolm, C.
Chem. Soc. Rev. 2014, 43, 2426.
(2) For selected examples: (a) Langner, M.; Bolm, C. Angew. Chem.,
Int. Ed. 2004, 43, 5984. (b) Frings, M.; Atodiresei, I.; Wang, Y.;
Runsink, J.; Raabe, G.; Bolm, C. Chem.Eur. J. 2010, 16, 4577.
(c) Bolm, C.; Simic, O. J. Am. Chem. Soc. 2001, 123, 3830.
(d) Harmata, M.; Ghosh, S. K. Org. Lett. 2001, 3, 3321. (e) Bolm,
C.; Martin, M.; Simic, O.; Verrucci, M. Org. Lett. 2003, 5, 427.
(3) Shen, X.; Zhang, W.; Ni, C.; Gu, Y.; Hu, J. J. Am. Chem. Soc.
2012, 134, 16999.
(4) (a) Dong, W.; Parthasarathy, K.; Cheng, Y.; Pan, F.; Bolm, C.
Chem.Eur. J. 2014, 20, 15732. (b) Parthasarathy, K.; Bolm, C.
Chem.Eur. J. 2014, 20, 4896. (c) Yadav, M. R.; Rit, R. K.; Sahoo, A.
K. Chem.Eur. J. 2012, 18, 5541. (d) Yadav, M. R.; Rit, R. K.;
Shankar, M.; Sahoo, A. K. J. Org. Chem. 2014, 79, 6123. (e) For
C(sp3)−H arylation, see: Rit, R. K.; Yadav, M. R.; Ghosh, K.; Shankar,
M.; Sahoo, A. K. Org. Lett. 2014, 16, 5258.
(5) Bentley, H. R.; Mcdermott, E. E.; Pace, J.; Whitehead, J. K.;
Moran, T. Nature 1949, 163, 675.
(6) For sulfoxaﬂor: Zhu, Y.; Loso, M. R.; Watson, G. B.; Sparks, T.
C.; Rogers, R. B.; Huang, J. X.; Gerwick, B. C.; Babcock, J. M.; Kelley,
D.; Hegde, V. B.; Nugent, B. M.; Renga, J. M.; Denholm, I.; Gorman,
K.; Deboer, G. J.; Hasler, J.; Meade, T.; Thomas, J. D. J. Agric. Food
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b00844
J. Org. Chem. 2015, 80, 6391−6399
6398
D
ow
nl
oa
de
d 
by
 IM
PE
RI
A
L 
CO
LL
EG
E 
LO
N
D
O
N
 o
n 
A
ug
us
t 2
7,
 2
01
5 
| ht
tp:
//p
ubs
.ac
s.o
rg 
 
Pu
bl
ic
at
io
n 
D
at
e 
(W
eb
): 
Ju
ne
 2,
 20
15
 | d
oi:
 10
.10
21/
acs
.jo
c.5
b00
844
Chem. 2011, 59, 2950. For sudexanox: Miller, P.; James, G. W. L. Arch.
Int. Pharmacodyn. Ther. 1978, 231, 328.
(7) Griffith, O. W.; Anderson, M. E.; Meister, A. J. Biol. Chem. 1979,
254, 1205.
(8) Lücking, U.; Jautelat, R.; Krüger, M.; Brumby, T.; Lienau, P.;
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